SCHEMBL29198178

SCHEMBL29198178

COc1cc(NC(=O)C2CCC(Nc3cccc(Nc4ncccn4)c3[N+](=O)[O-])CC2)ccc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.43
▸ ROS1 P08922 1/20 0.43
▸ ALK Q9UM73 1/20 0.43
▸ GRM4 Q14833 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ MALT1 Q9UDY8 7/20 0.41
▸ BTK Q06187 1/20 0.40
▸ LMNA P02545 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KDM4E B2RXH2 2/20 0.38
▸ TUBB4A P04350 1/20 0.38
▸ TUBB P07437 1/20 0.38
▸ TUBA3C P0DPH7 1/20 0.38
▸ TUBA1B P68363 1/20 0.38
▸ TUBA4A P68366 1/20 0.38
▸ TUBB4B P68371 1/20 0.38
▸ TUBB3 Q13509 1/20 0.38
▸ TUBB2A Q13885 1/20 0.38
▸ TUBB8 Q3ZCM7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30870547 1.00 EGFR (0.43) EGFRROS1ALKGRM4POLB
SCHEMBL28502106 0.85 POLB (0.45) GRM4POLBLMNAMAPK1HTT
SCHEMBL30870626 0.85 POLB (0.45) GRM4POLBLMNAMAPK1HTT
SCHEMBL29198168 0.85 POLB (0.44) GRM4POLBLMNAMAPK1HTT
SCHEMBL29198166 0.85 POLB (0.44) GRM4POLBLMNAMAPK1HTT
SCHEMBL30870533 0.85 POLB (0.44) GRM4POLBLMNAMAPK1HTT
SCHEMBL29198258 0.84 POLB (0.43) EGFRROS1ALKGRM4POLB
SCHEMBL28512461 0.82 MAPT (0.49) POLBMALT1LMNAHTTKDM4E
SCHEMBL30870559 0.82 MAPT (0.49) POLBMALT1LMNAHTTKDM4E
SCHEMBL30870543 0.82 POLB (0.40) EGFRROS1ALKGRM4POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112074511-B Substituted benzodiazoles and their use in therapy 托马斯·黑勒戴药物研究基金会 2024-04-26 — — CN disclosed
Send feedback